Barclays PLC Guardant Health, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Barclays PLC holds 887,031 shares of GH stock, worth $28.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

887,031

Previous 887,031 -0.0%

Holding current value

$28.1 Million

Previous $20.3 Million -0.0%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$22.3 - $36.29 $9.14 Million - $14.9 Million	409,659 Added 85.82%	887,031 $20.3 Million
Q2 2024 Aug 14, 2024	SELL	$16.07 - $31.84 $6.71 Million - $13.3 Million	-417,468 Reduced 46.65%	477,372 $13.8 Million
Q1 2024 May 15, 2024	BUY	$17.13 - $26.91 $7.95 Million - $12.5 Million	464,085 Added 107.74%	894,840 $18.5 Million
Q4 2023 Feb 15, 2024	BUY	$21.58 - $29.5 $3.34 Million - $4.56 Million	154,656 Added 56.01%	430,755 $11.7 Million
Q3 2023 Nov 07, 2023	BUY	$25.8 - $39.97 $1.89 Million - $2.93 Million	73,227 Added 36.1%	276,099 $8.18 Million
Q2 2023 Aug 03, 2023	BUY	$20.94 - $38.01 $1.06 Million - $1.92 Million	50,428 Added 33.08%	202,872 $7.26 Million
Q1 2023 May 04, 2023	BUY	$22.92 - $33.76 $185,927 - $273,861	8,112 Added 5.62%	152,444 $3.57 Million
Q4 2022 Feb 13, 2023	SELL	$25.44 - $59.78 $847,584 - $1.99 Million	-33,317 Reduced 18.75%	144,332 $3.93 Million
Q3 2022 Nov 03, 2022	BUY	$43.66 - $61.0 $717,901 - $1 Million	16,443 Added 10.2%	177,649 $9.56 Million
Q2 2022 Aug 12, 2022	SELL	$28.82 - $77.35 $1.31 Million - $3.51 Million	-45,346 Reduced 21.95%	161,206 $6.5 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $857,788 - $1.79 Million	17,778 Added 9.42%	206,552 $13.7 Million
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $370,807 - $503,397	-4,180 Reduced 2.17%	188,774 $18.9 Million
Q3 2021 Nov 09, 2021	SELL	$98.77 - $132.17 $4.55 Million - $6.09 Million	-46,063 Reduced 19.27%	192,954 $24.1 Million
Q2 2021 Aug 13, 2021	BUY	$109.77 - $165.68 $5.89 Million - $8.89 Million	53,680 Added 28.96%	239,017 $29.7 Million
Q1 2021 May 13, 2021	SELL	$127.04 - $179.1 $1.24 Million - $1.75 Million	-9,760 Reduced 5.0%	185,337 $28.3 Million
Q4 2020 Feb 11, 2021	BUY	$99.96 - $135.93 $19.4 Million - $26.4 Million	194,547 Added 35372.18%	195,097 $25.1 Million
Q3 2020 Nov 12, 2020	BUY	$80.32 - $111.8 $26,907 - $37,453	335 Added 155.81%	550 $61,000
Q2 2020 Aug 12, 2020	SELL	$60.49 - $97.5 $440,669 - $710,287	-7,285 Reduced 97.13%	215 $17,000
Q1 2020 May 13, 2020	SELL	$59.04 - $88.81 $9.61 Million - $14.5 Million	-162,722 Reduced 95.59%	7,500 $522,000
Q4 2019 Feb 10, 2020	BUY	$59.49 - $82.78 $4.44 Million - $6.17 Million	74,567 Added 77.95%	170,222 $13.3 Million
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $4.83 Million - $8.52 Million	77,245 Added 419.58%	95,655 $6.11 Million
Q2 2019 Aug 14, 2019	SELL	$63.94 - $91.11 $781,794 - $1.11 Million	-12,227 Reduced 39.91%	18,410 $1.59 Million
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $444,596 - $1.27 Million	12,962 Added 73.34%	30,637 $2.35 Million
Q4 2018 Feb 14, 2019	BUY	$29.2 - $46.1 $516,110 - $814,817	17,675 New	17,675 $664,000

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.24B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account